Tiziana Life Sciences (TLSA) announced that its CEO Ivor Elrifi, has purchased 193,848 shares of Tiziana common stock at a price of $1.65 per share in the open market.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Chairman Increases Stake with Recent Share Purchase
- Tiziana Life Sciences announces purchase of shares by chairman
- Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab
- Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
- FDA Approves Tiziana Life Sciences’ Phase 2a Trial for MSA